BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22222639)

  • 1. Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.
    Morgado JM; Sánchez-Muñoz L; Teodósio CG; Jara-Acevedo M; Alvarez-Twose I; Matito A; Fernández-Nuñez E; García-Montero A; Orfao A; Escribano L
    Mod Pathol; 2012 Apr; 25(4):516-21. PubMed ID: 22222639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.
    Jabbar KJ; Medeiros LJ; Wang SA; Miranda RN; Johnson MR; Verstovsek S; Jorgensen JL
    Arch Pathol Lab Med; 2014 Sep; 138(9):1210-4. PubMed ID: 25171703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis.
    Cherian S; McCullouch V; Miller V; Dougherty K; Fromm JR; Wood BL
    Cytometry B Clin Cytom; 2016 Jul; 90(4):387-92. PubMed ID: 26525770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotyping of mast cells: a sensitive and specific diagnostic tool for systemic mastocytosis.
    van Daele PL; Beukenkamp BS; Geertsma-Kleinekoort WM; Valk PJ; van Laar JA; van Hagen PM; van der Velden VH
    Neth J Med; 2009 Apr; 67(4):142-6. PubMed ID: 19581658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.
    Perbellini O; Zamò A; Colarossi S; Zampieri F; Zoppi F; Bonadonna P; Schena D; Artuso A; Martinelli G; Chilosi M; Pizzolo G; Zanotti R
    Cytometry B Clin Cytom; 2011 Nov; 80(6):362-8. PubMed ID: 21656905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
    Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
    Pozdnyakova O; Kondtratiev S; Li B; Charest K; Dorfman DM
    Am J Clin Pathol; 2012 Sep; 138(3):416-24. PubMed ID: 22912359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
    Berezowska S; Flaig MJ; Ruëff F; Walz C; Haferlach T; Krokowski M; Kerler R; Petat-Dutter K; Horny HP; Sotlar K
    Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
    Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
    Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
    Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
    Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow.
    Johnson MR; Verstovsek S; Jorgensen JL; Manshouri T; Luthra R; Jones DM; Bueso-Ramos CE; Medeiros LJ; Huh YO
    Mod Pathol; 2009 Jan; 22(1):50-7. PubMed ID: 19116630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
    Baumgartner C; Sonneck K; Krauth MT; Kneidinger M; Födinger M; Hauswirth AW; Müllauer L; Valent P
    Eur J Clin Invest; 2008 May; 38(5):326-35. PubMed ID: 18363719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.
    Akin C; Valent P; Escribano L
    Curr Allergy Asthma Rep; 2006 Jul; 6(4):282-8. PubMed ID: 16822380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease.
    Fernandes IC; Teixeira Mdos A; Freitas I; Selores M; Alves R; Lima M
    An Bras Dermatol; 2014; 89(1):59-66. PubMed ID: 24626649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotype of pediatric-onset mastocytosis does not correlate with clinical course.
    Greenberger S; Landov H; Confino Y; Vaknine H; Avivi C; Baum S; Barzilai A
    Pediatr Dermatol; 2019 Jul; 36(4):477-481. PubMed ID: 31120154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.